Repositorio Dspace

Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and Oncosis

Mostrar el registro sencillo del ítem

dc.contributor.author Kasparkova, Jana
dc.contributor.author Hernández-García, Alba
dc.contributor.author Kostrhunova, Hana
dc.contributor.author Goicuria, Marta
dc.contributor.author Novohradsky, Vojtech
dc.contributor.author Bautista, Delia
dc.contributor.author Markova, Lenka
dc.contributor.author Santana, María-Dolores
dc.contributor.author Brabec, Viktor
dc.contributor.author Ruiz, José
dc.date.accessioned 2025-11-27T09:37:04Z
dc.date.available 2025-11-27T09:37:04Z
dc.date.issued 2023-12-23
dc.identifier.citation Kasparkova J, Hernández-García A, Kostrhunova H, Goicuría M, Novohradsky V, Bautista D, et al. Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and Oncosis. J Med Chem. 11 de enero de 2024;67(1):691-708.
dc.identifier.issn 0022-2623
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22825
dc.description.abstract A second-generation series of biscyclometalated 2-(5-aryl-thienyl)-benzimidazole and -benzothiazole Ir(III) dppz complexes [Ir(C^N)(2)(dppz)](+), Ir1-Ir4, were rationally designed and synthesized, where the aryl group attached to the thienyl ring was p-CF(3)C(6)H(4) or p-Me(2)NC(6)H(4). These new Ir(III) complexes were assessed as photosensitizers to explore the structure-activity correlations for their potential use in biocompatible anticancer photodynamic therapy. When irradiated with blue light, the complexes exhibited high selective potency across several cancer cell lines predisposed to photodynamic therapy; the benzothiazole derivatives (Ir1 and Ir2) were the best performers, Ir2 being also activatable with green or red light. Notably, when irradiated, the complexes induced leakage of lysosomal content into the cytoplasm of HeLa cancer cells and induced oncosis-like cell death. The capability of the new Ir complexes to photoinduce cell death in 3D HeLa spheroids has also been demonstrated. The investigated Ir complexes can also catalytically photo-oxidate NADH and photogenerate (1)O(2) and/or (-)OH in cell-free media.
dc.language.iso eng
dc.publisher AMER CHEMICAL SOC
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/ *
dc.subject.mesh Humans
dc.subject.mesh Coordination Complexes/pharmacology
dc.subject.mesh Iridium/pharmacology
dc.subject.mesh Photosensitizing Agents/pharmacology/therapeutic use
dc.subject.mesh Dermatitis, Phototoxic/drug therapy
dc.subject.mesh Lysosomes
dc.subject.mesh Benzothiazoles
dc.subject.mesh Antineoplastic Agents/pharmacology
dc.subject.mesh Cell Line, Tumor
dc.subject.mesh Neoplasms/drug therapy
dc.title Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and Oncosis
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 38141031
dc.relation.publisherversion https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c01978
dc.identifier.doi 10.1021/acs.jmedchem.3c01978
dc.journal.title Journal of Medicinal Chemistry
dc.identifier.essn 1520-4804


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta